Carboxymethyl Chitosan Microgels for Sustained Delivery of Vancomycin and Long-Lasting Antibacterial Effects

Enhanced Antibacterial Activity of Vancomycin Loaded on Functionalized Polyketones

Today, polymeric drug delivery systems (DDS) appear as an interesting solution against bacterial resistance, having great advantages such as low toxicity, biocompatibility, and biodegradability. In this work, two polyketones (PK) have been post-functionalized with sodium taurinate (PKT) or potassium sulfanilate (PKSK) and employed as carriers for Vancomycin against bacterial infections. Modified PKs were easily prepared by the Paal-Knorr reaction and loaded with Vancomycin at a variable pH. All polymers were characterized by FT-IR, DSC, TGA, SEM, and elemental analysis. Antimicrobial activity was tested against Gram-positive Staphylococcus aureus ATCC 25923 and correlated to the different pHs used for its loading (between 2.3 and 8.8). In particular, the minimum inhibitory concentrations achieved with PKT and PKSK loaded with Vancomycin were similar, at 0.23 μg/mL and 0.24 μg/mL, respectively, i.e., six times lower than that with Vancomycin alone. The use of post-functionalized aliphatic polyketones has thus been demonstrated to be a promising way to obtain very efficient polymeric DDS.

Synthesis, Characterization, and Evaluation of Silver Nanoparticle-Loaded Carboxymethyl Chitosan with Sulfobetaine Methacrylate Hydrogel Nanocomposites for Biomedical Applications

In this study, nanocomposites of AgNPs encapsulated in carboxymethyl chitosan (CMCS) with sulfobetaine methacrylate (SB) hydrogel (AgNPs/CMCS-SB) were synthesized. The UV-Vis spectra indicated the presence of AgNPs, with a broad peak at around 424 nm, while the AgNPs-loaded CMCS-SB nanocomposite exhibited absorption peaks at 445 nm. The size and dispersion of AgNPs varied with the concentration of the AgNO3 solution, affecting swelling rates: 148.37 ± 15.63%, 172.26 ± 18.14%, and 159.17 ± 16.59% for 1.0 mM, 3.0 mM, and 5.0 mM AgNPs/CMCS-SB, respectively. Additionally, water absorption capacity increased with AgNPs content, peaking at 11.04 ± 0.54% for the 3.0 mM AgNPs/CMCS-SB nanocomposite. Silver release from the nanocomposite was influenced by AgNO3 concentration, showing rapid initial release followed by a slower rate over time for the 3.0 mM AgNPs/CMCS-SB. XRD patterns affirmed the presence of AgNPs, showcasing characteristic peaks indicative of a face-centered cubic (fcc) structure. The FTIR spectra highlighted interactions between AgNPs and CMCS-SB, with noticeable shifts in characteristic bands. In addition, SEM and TEM images validated spherical AgNPs within the CMCS-SB hydrogel network, averaging approximately 70 and 30 nm in diameter, respectively. The nanocomposite exhibited significant antibacterial activity against S. aureus and E. coli, with inhibition rates of 98.9 ± 0.21% and 99.2 ± 0.14%, respectively, for the 3.0 mM AgNPs/CMCS-SB nanocomposite. Moreover, cytotoxicity assays showcased the efficacy of AgNPs/CMCS-SB against human colorectal cancer cells (HCT-116 cells), with the strongest cytotoxicity (61.7 ± 4.3%) at 100 μg/mL. These results suggest the synthesized AgNPs/CMCS-SB nanocomposites possess promising attributes for various biomedical applications, including antimicrobial and anticancer activities, positioning them as compelling candidates for further advancement in biomedicine.

Recent developments in chitosan based microgels and their hybrids

Chitosan based microgels have gained great attention because of their chemical stability, biocompatibility, easy functionalization and potential uses in numerous fields. Production, properties, characterization and applications of chitosan based microgels have been systematically reviewed in this article. Some of these systems exhibit responsive behavior towards external stimuli like pH, light, temperature, glucose, etc. in terms of swelling/deswelling in an aqueous medium depending upon the functionalities present in the network which makes them a potential candidate for various applications in the fields of biomedicine, agriculture, catalysis, sensing and nanotechnology. Current research development and critical overview in this field accompanying by future possibilities is presented. The discussion is concluded with recommended possible future works for further progress in this field.

Current developments and prospects of the antibiotic delivery systems

Antibiotics have remained the cornerstone for the treatment of bacterial infections ever since their discovery in the twentieth century. The uproar over antibiotic resistance among bacteria arising from genome plasticity and biofilm development has rendered current antibiotic therapies ineffective, urging the development of innovative therapeutic approaches. The development of antibiotic resistance among bacteria has further heightened the clinical failure of antibiotic therapy, which is often linked to its low bioavailability, side effects, and poor penetration and accumulation at the site of infection. In this review, we highlight the potential use of siderophores, antibodies, cell-penetrating peptides, antimicrobial peptides, bacteriophages, and nanoparticles to smuggle antibiotics across impermeable biological membranes to achieve therapeutically relevant concentrations of antibiotics and combat antimicrobial resistance (AMR). We will discuss the general mechanisms via which each delivery system functions and how it can be tailored to deliver antibiotics against the paradigm of mechanisms underlying antibiotic resistance.